Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-25 @ 9:19 PM
Study NCT ID:
NCT04530656
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2020-08-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-27
First Submit QC Date:
None
Study First Post Date:
2020-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-31
Last Update Post Date:
2022-06-01
Last Update Post Date Type:
ACTUAL